Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
OncLive Global Expo
Giants of Cancer Care
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>

Ovarian Cancer Videos

Future Directions in Advanced Ovarian Cancer Management
Future Directions in Advanced Ovarian Cancer Management
Experts consider the future direction of advanced ovarian cancer management given advances with novel therapeutics and screening.
Insights   >   Expanding Role of PARP Inhibitors in Advanced Ovarian Cancer
Genetic Counseling for Patients With Ovarian Cancer
Genetic Counseling for Patients With Ovarian Cancer
Key opinion leaders reflect on the value of genetic counseling for patients with advanced ovarian cancer.
Insights   >   Expanding Role of PARP Inhibitors in Advanced Ovarian Cancer
Sequencing Antiangiogenic Agents in Advanced Ovarian Cancer
Sequencing Antiangiogenic Agents in Advanced Ovarian Cancer
In conjunction to sequencing PARP inhibitors, experts share their perspective on the potential use of antiangiogenic agents in ovarian cancer.
Insights   >   Expanding Role of PARP Inhibitors in Advanced Ovarian Cancer
Outlook in Treating Patients With Ovarian Cancer
Outlook in Treating Patients With Ovarian Cancer
Clinical experts consider the rapid evolvements occurring in the treatment of ovarian cancer and remark on strategies for optimizing patient care as the field moves forward.
Peer Exchange   >   Shifting Paradigms in Ovarian Cancer
Ongoing Research in Ovarian Cancer
Ongoing Research in Ovarian Cancer
A clinical overview of ongoing studies that are further investigating the potential role of novel therapies for the treatment of ovarian cancer.
 
Peer Exchange   >   Shifting Paradigms in Ovarian Cancer
I/O Combination Strategies in Ovarian Cancer
I/O Combination Strategies in Ovarian Cancer
Insight regarding the potential for treating appropriate patients with ovarian cancer with combination regimens that include immunotherapy.
Peer Exchange   >   Shifting Paradigms in Ovarian Cancer
Sequencing PARP Inhibitors in Advanced Ovarian Cancer
Sequencing PARP Inhibitors in Advanced Ovarian Cancer
Given the rapidly changing treatment landscape in advanced ovarian cancer, an expert explains possible sequencing approaches with PARP inhibitors.
Insights   >   Expanding Role of PARP Inhibitors in Advanced Ovarian Cancer
Prepping Patients With Advanced OC for PARP Inhibition
Prepping Patients With Advanced OC for PARP Inhibition
Kathleen Moore, MD, delivers advice on patient preparation and adherence with regard to adverse events tied to PARP inhibition.
Insights   >   Expanding Role of PARP Inhibitors in Advanced Ovarian Cancer
Dr. Penson on Olaparib Monotherapy Vs Chemo in Ovarian Cancer
Dr. Penson on Olaparib Monotherapy Vs Chemo in Ovarian Cancer
Richard T. Penson, MD, MRCP, associate professor, Harvard Medical School, and clinical director, Medical Gynecologic Oncology, Massachusetts General Hospital, compares olaparib (Lynparza) monotherapy with chemotherapy for patients with relapsed germline BRCA-mutated (gBRCAm) platinum-sensitive ovarian cancer.
Onclive TV   >   
Rationale for Immunotherapy in Ovarian Cancer
Rationale for Immunotherapy in Ovarian Cancer
Ovarian cancer experts discuss the potential for treating patients with recurrent ovarian cancer with immunotherapy based on data revealed through trials such as the KEYNOTE-100 study.
Peer Exchange   >   Shifting Paradigms in Ovarian Cancer
Next Page >>
Publication Bottom Border
Border Publication
 
x